モルヒネ製剤の世界市場

モルヒネ製剤の世界市場は2030年までに300億米ドルに達する見込み

2024年に242億米ドルと推定されるモルヒネ製剤の世界市場は、2024年から2030年にかけてCAGR 3.6%で成長し、2030年には300億米ドルに達すると予測されます。本レポートで分析したセグメントの1つである経口剤は、CAGR 4.6%を記録し、分析期間終了時には182億米ドルに達すると予測されます。注射剤セグメントの成長率は、分析期間中CAGR 2.0%と推定されます。

米国市場は66億米ドルと推定、中国はCAGR6.9%で成長予測

米国のモルヒネ製剤市場は2024年に66億米ドルと推定されます。世界第2位の経済大国である中国は、2030年までに61億米ドルの市場規模に達すると予測され、分析期間2024-2030年のCAGRは6.9%です。その他の注目すべき地域別市場としては、日本とカナダがあり、分析期間中のCAGRはそれぞれ1.4%と2.8%と予測されています。欧州では、ドイツがCAGR 2.1%で成長すると予測されています。

世界のモルヒネ製剤市場- 主要動向と促進要因まとめ

疼痛管理におけるモルヒネ製剤の需要はどのように進化しているか？

最も広く使用されているオピオイド鎮痛薬の1つであるモルヒネは、特に手術後の回復、がん疼痛管理、緩和ケアなど、激痛治療の要であり続けています。効果的な鎮痛を必要とする慢性疼痛障害、筋骨格系疾患、末期疾患の有病率の増加により、モルヒネ製剤に対する世界の需要が高まっています。ヘルスケア機関や疼痛管理クリニックでは、患者のQOLを向上させるためにモルヒネの管理使用を推奨する傾向が強まっており、その強力な鎮痛特性が責任をもって使用され、苦痛が軽減されることを保証しています。しかし、オピオイド処方を取り巻く規制の枠組みが厳しく、オピオイド中毒に対する懸念が高まっていることから、いくつかの国では厳格な監視プログラムが実施されています。市場はまた、患者がモルヒネの制御量を自己投与できるようにする患者制御鎮痛（PCA）システムへのシフトを目の当たりにしており、鎮痛効果を向上させながら過剰摂取のリスクを減らしています。さらに、徐放性製剤や経皮パッチなどのドラッグデリバリー機構の進歩により、モルヒネ治療の有効性と安全性が向上し、長期的な疼痛管理に適しています。

モルヒネ市場を変える製剤の革新とは？

モルヒネ製剤の進化は、オピオイドの誤用に伴う潜在的なリスクを最小限に抑えつつ、その治療用途を改善する上で重要な役割を果たしています。製薬会社は研究開発に投資し、より低い依存性リスクで鎮痛効果を持続させる徐放性モルヒネ製剤を開発しています。リポソーム製剤や乱用抑止製剤（ADF）などの新しいドラッグデリバリーシステムは、意図しない薬物操作を防ぎ、オピオイドに関連する合併症の可能性を低減することから、支持を集めています。さらに、舌下製剤、頬側製剤、静脈内投与製剤は、急性疼痛の場面でより速い作用発現を実現するために改良が加えられています。モルヒネと非オピオイド鎮痛薬との併用療法の導入も、効果的な鎮痛を維持しながらオピオイド依存を減らすことを目的とした新たな動向です。さらに、バイオテクノロジー企業は、モルヒネの鎮痛特性を模倣しつつ、中毒の可能性が低い代替オピオイド受容体作動薬を研究しており、次世代の疼痛管理ソリューションへの道を開いています。

規制政策と消費者意識は市場力学にどのような影響を与えているか？

モルヒネ製剤の使用を規制する枠組みは、特にオピオイド危機の影響を受けている地域において、市場の成長に大きな影響を与えています。各国政府やヘルスケア機関は、責任あるオピオイド使用を確保するために、厳格な処方ガイドライン、電子監視システム、国民意識向上キャンペーンを実施しています。病院やクリニックにおけるオピオイド・スチュワードシップ・プログラムの確立は、過剰処方の事例を防止しつつ、モルヒネ処方のベストプラクティスについて医療従事者を教育することを目的としています。さらに、オピオイド薬に対する一般市民の認識も変化しており、依存症のリスクに対する認識が高まるにつれて、患者は代替の疼痛管理療法を模索するようになっています。このため、オピオイドの処方にはより慎重なアプローチが求められるようになり、理学療法、非オピオイド鎮痛薬、インターベンションなどの補完的疼痛管理戦略の開発が奨励されています。これを受けて、製薬会社は規制遵守に注力し、ヘルスケアプロバイダーと緊密に連携して、入手しやすさと流通のコントロールのバランスを取りながら、モルヒネが激痛に苦しむ患者にとって不可欠なツールであり続けるよう努力しています。

モルヒネ製剤市場の主な成長促進要因は？

世界のモルヒネ製剤市場の成長は、慢性疼痛や術後疼痛の発生率の上昇、効果的な緩和ケアのニーズの高まり、ドラッグデリバリー技術の進歩など、いくつかの要因によってもたらされます。主な促進要因のひとつは、疼痛管理クリニックや重症・末期患者を対象とした専門治療センターの拡大です。乱用抑止型製剤や放出制御型製剤の開発も、オピオイド療法に伴う安全性の懸念に対処することで市場開拓に拍車をかけています。慢性疼痛に罹患しやすい老年人口の増加が、効果的な疼痛緩和ソリューションへの需要をさらに押し上げています。さらに、鎮痛効果を維持しながら依存リスクを低減するオピオイドベースの代替薬の研究が進んでいることも、情勢を拡大させています。さらに、新興国市場で必要不可欠な鎮痛薬へのアクセスを改善することを目的とした政府の取り組みも、市場拡大に寄与しています。遺伝的・代謝的要因に基づいて疼痛管理を行う個別化医療の採用も、モルヒネ製剤の需要を支える新たな動向です。技術の進歩が医薬品の状況を形成し続ける中、市場情勢は、アクセシビリティ、安全性、規制状況のバランスを取りながら進化していくと予想されます。

セグメント

剤形（経口剤、注射剤、その他の剤形）、流通チャネル（病院薬局、小売薬局、オンライン薬局、その他の流通チャネル）、用途（疼痛管理用途、下痢止め用途、風邪・咳止め用途、その他の用途）、最終用途（病院・クリニック最終用途、外来手術センター最終用途、その他の最終用途）

調査対象企業の例

• AbbVie Inc.
• AstraZeneca plc
• Bayer AG
• Boehringer Ingelheim GmbH
• Eli Lilly and Company
• Endo International plc
• Fresenius Kabi AG
• GlaxoSmithKline plc
• Hikma Pharmaceuticals plc
• Johnson & Johnson
• Mallinckrodt Pharmaceuticals
• Merck & Co., Inc.
• Mylan N.V.
• Novartis International AG
• Pfizer Inc.
• Purdue Pharma L.P.
• Sanofi S.A.
• Sun Pharmaceutical Industries Ltd.
• Takeda Pharmaceutical Company Ltd.
• Teva Pharmaceutical Industries Ltd.

AIインテグレーション

Global Industry Analystsは、有効な専門家コンテンツとAIツールによって、市場情報と競合情報を変革しています。

Global Industry Analystsは、一般的なLLMや業界固有のSLMにクエリーする代わりに、ビデオ記録、ブログ、検索エンジン調査、大量の企業、製品/サービス、市場データなど、世界中の専門家からキュレートされたコンテンツのリポジトリを構築しました。

関税影響係数

Global Industry Analystsは、本社の国、製造拠点、輸出入（完成品とOEM）に基づく企業の競争力の変化を予測しています。この複雑で多面的な市場力学は、売上原価（COGS）の増加、収益性の低下、サプライチェーンの再構築など、ミクロおよびマクロの市場力学の中でも特に競合他社に影響を与える見込みです。

目次

第1章 調査手法

第2章 エグゼクティブサマリー

• 市場概要
• 主要企業
• 市場動向と促進要因
• 世界市場の見通し

第3章 市場分析

• 米国
• カナダ
• 日本
• 中国
• 欧州
• フランス
• ドイツ
• イタリア
• 英国
• スペイン
• ロシア
• その他欧州
• アジア太平洋
• オーストラリア
• インド
• 韓国
• その他アジア太平洋地域
• ラテンアメリカ
• アルゼンチン
• ブラジル
• メキシコ
• その他ラテンアメリカ
• 中東
• イラン
• イスラエル
• サウジアラビア
• アラブ首長国連邦
• その他中東
• アフリカ

第4章 競合

Global Morphine Drugs Market to Reach US$30.0 Billion by 2030

The global market for Morphine Drugs estimated at US$24.2 Billion in the year 2024, is expected to reach US$30.0 Billion by 2030, growing at a CAGR of 3.6% over the analysis period 2024-2030. Oral Form, one of the segments analyzed in the report, is expected to record a 4.6% CAGR and reach US$18.2 Billion by the end of the analysis period. Growth in the Injection Form segment is estimated at 2.0% CAGR over the analysis period.

The U.S. Market is Estimated at US$6.6 Billion While China is Forecast to Grow at 6.9% CAGR

The Morphine Drugs market in the U.S. is estimated at US$6.6 Billion in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$6.1 Billion by the year 2030 trailing a CAGR of 6.9% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 1.4% and 2.8% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 2.1% CAGR.

Global Morphine Drugs Market - Key Trends & Drivers Summarized

How Is the Demand for Morphine Drugs Evolving in Pain Management?

Morphine, one of the most widely used opioid analgesics, continues to be a cornerstone in the treatment of severe pain, particularly in post-surgical recovery, cancer pain management, and palliative care. The global demand for morphine drugs has been rising due to the increasing prevalence of chronic pain disorders, musculoskeletal conditions, and terminal illnesses requiring effective pain relief. Healthcare institutions and pain management clinics are increasingly advocating the controlled use of morphine to improve patients' quality of life, ensuring that its potent analgesic properties are used responsibly to mitigate suffering. However, the stringent regulatory framework surrounding opioid prescriptions and the growing concerns over opioid addiction have led to the implementation of strict monitoring programs in several countries. The market is also witnessing a shift toward patient-controlled analgesia (PCA) systems, which allow patients to self-administer controlled doses of morphine, reducing the risk of overdose while improving pain relief outcomes. Furthermore, advancements in drug delivery mechanisms, including extended-release formulations and transdermal patches, are enhancing the efficacy and safety of morphine therapy, making it more suitable for long-term pain management.

What Innovations in Drug Formulations Are Transforming the Morphine Market?

The evolution of morphine drug formulations has played a crucial role in improving its therapeutic applications while minimizing potential risks associated with opioid misuse. Pharmaceutical companies are investing in research and development to create modified-release morphine formulations that provide prolonged analgesia with lower risks of dependency. Novel drug delivery systems, including liposomal formulations and abuse-deterrent formulations (ADFs), are gaining traction as they prevent unintended drug manipulation and reduce the likelihood of opioid-related complications. Additionally, sublingual, buccal, and intravenous formulations are being refined to provide faster onset of action for acute pain scenarios. The introduction of combination therapies, where morphine is paired with non-opioid analgesics, is another emerging trend aimed at reducing opioid dependency while maintaining effective pain relief. Furthermore, biotechnology firms are exploring alternative opioid receptor agonists that mimic morphine’s analgesic properties while exhibiting a lower potential for addiction, paving the way for next-generation pain management solutions.

How Are Regulatory Policies and Consumer Awareness Impacting Market Dynamics?

Regulatory frameworks governing the use of morphine drugs have had a significant impact on market growth, particularly in regions affected by the opioid crisis. Governments and healthcare organizations are implementing stringent prescription guidelines, electronic monitoring systems, and public awareness campaigns to ensure responsible opioid use. The establishment of opioid stewardship programs in hospitals and clinics is aimed at educating healthcare professionals on best practices for prescribing morphine while preventing cases of overprescription. Additionally, public perception of opioid medications is shifting, with increased awareness of the risks of dependency leading patients to explore alternative pain management therapies. This has led to a more cautious approach in opioid prescribing, encouraging the development of complementary pain management strategies such as physiotherapy, non-opioid analgesics, and interventional procedures. In response, pharmaceutical companies are focusing on regulatory compliance and working closely with healthcare providers to balance accessibility with controlled distribution, ensuring that morphine remains an essential tool for patients experiencing severe pain.

What Are the Key Growth Drivers in the Morphine Drugs Market?

The growth in the global morphine drugs market is driven by several factors, including the rising incidence of chronic and post-operative pain conditions, the increasing need for effective palliative care, and advancements in controlled drug delivery technologies. One of the primary drivers is the expansion of pain management clinics and specialized treatment centers that cater to patients with severe or terminal illnesses. The development of abuse-deterrent formulations and controlled-release morphine drugs has also fueled market growth by addressing safety concerns associated with opioid therapy. The growing geriatric population, which is more susceptible to chronic pain conditions, is further driving demand for effective pain relief solutions. Moreover, ongoing research into alternative opioid-based medications that reduce dependency risks while maintaining analgesic efficacy is expanding the therapeutic landscape for morphine drugs. Additionally, government initiatives aimed at improving access to essential pain relief medications in developing regions are contributing to market expansion. The adoption of personalized medicine approaches, where pain management is tailored based on genetic and metabolic factors, is another emerging trend supporting the demand for morphine drugs. As technological advancements continue to shape the pharmaceutical landscape, the morphine drugs market is expected to evolve, striking a balance between accessibility, safety, and regulatory compliance.

SCOPE OF STUDY:

The report analyzes the Morphine Drugs market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Dosage Form (Oral Form, Injection Form, Other Dosage Forms); Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, Other Distribution Channels); Application (Pain Management Application, Diarrhea Suppressant Application, Cold & Cough Suppressant Application, Other Applications); End-Use (Hospitals & Clinics End-Use, Ambulatory Surgery Centers End-Use, Other End-Uses)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 34 Featured) -

• AbbVie Inc.
• AstraZeneca plc
• Bayer AG
• Boehringer Ingelheim GmbH
• Eli Lilly and Company
• Endo International plc
• Fresenius Kabi AG
• GlaxoSmithKline plc
• Hikma Pharmaceuticals plc
• Johnson & Johnson
• Mallinckrodt Pharmaceuticals
• Merck & Co., Inc.
• Mylan N.V.
• Novartis International AG
• Pfizer Inc.
• Purdue Pharma L.P.
• Sanofi S.A.
• Sun Pharmaceutical Industries Ltd.
• Takeda Pharmaceutical Company Ltd.
• Teva Pharmaceutical Industries Ltd.

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

• 1. MARKET OVERVIEW
  • Influencer Market Insights
  • Tariff Impact on Global Supply Chain Patterns
  • Morphine Drugs - Global Key Competitors Percentage Market Share in 2025 (E)
  • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
• 2. FOCUS ON SELECT PLAYERS
• 3. MARKET TRENDS & DRIVERS
  • Rising Global Incidence of Chronic Pain Drives Growth in Demand for Morphine-Based Pain Relief Solutions
  • Increasing Prevalence of Post-surgical Pain and Cancer-related Pain Expands Market Opportunity for Morphine Drugs
  • Growing Focus on Palliative and Hospice Care Increases Adoption of Morphine Drugs in Pain Management
  • Advances in Drug Delivery Systems for Morphine Enhance Efficacy and Market Potential for Pain Relief Treatments
  • Increasing Government Regulations on Opioid Use and Misuse Challenges the Morphine Drugs Market and Drives Innovation in Safer Formulations
  • Ongoing Research and Development in Pain Management Therapies Stimulates Innovation in Morphine Drug Alternatives
  • Growing Patient Demand for Effective and Rapid-acting Pain Relief Solutions Expands Market for Morphine Drugs
  • Increasing Awareness of Pain Management Options Strengthens Business Case for Morphine as a Primary Treatment for Severe Pain
  • Surge in Cancer Diagnoses Drives Long-term Growth in Morphine Drug Demand for Terminal Care and Pain Relief
  • Aging Population and Rising Healthcare Costs Accelerate Demand for Morphine in Chronic Pain and Elderly Care
  • Increased Focus on Personalized Pain Management Strategies Propels the Adoption of Targeted Morphine Treatments
  • Expansion of Retail and Online Pharmacies Increases Access to Morphine Drugs for Patients in Remote and Underserved Areas
  • Rising Incidents of Opioid Addiction and Abuse Heighten Regulatory Scrutiny and Drive Market Shifts in Morphine Drug Formulations
  • Stronger Focus on Patient Education and Risk Mitigation Measures in Opioid Use Drives Safer Morphine Prescriptions and Usage Patterns
  • Demand for Extended-release Morphine Formulations Expands Market Opportunities for Long-acting Pain Relief Solutions
  • Regulatory Approvals and Guidelines for Abuse-deterrent Morphine Formulations Strengthen Adoption of Safer Pain Relief Drugs
  • Shift Towards Non-opioid Pain Management Solutions Challenges the Market Growth of Traditional Morphine Drugs
  • Strategic Partnerships Between Pharmaceutical Companies and Healthcare Providers Drive the Distribution and Prescription of Morphine Drugs
  • Increasing Availability of Generic Morphine Drugs Drives Price Competition and Expands Market Access
  • Government and International Initiatives to Combat Opioid Crisis Encourage Research into Morphine Alternatives and Safer Delivery Systems
• 4. GLOBAL MARKET PERSPECTIVE
  • TABLE 1: World Morphine Drugs Market Analysis of Annual Sales in US$ Million for Years 2015 through 2030
  • TABLE 2: World Recent Past, Current & Future Analysis for Morphine Drugs by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 3: World Historic Review for Morphine Drugs by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 4: World 15-Year Perspective for Morphine Drugs by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2015, 2025 & 2030
  • TABLE 5: World Recent Past, Current & Future Analysis for Oral Form by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 6: World Historic Review for Oral Form by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 7: World 15-Year Perspective for Oral Form by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 8: World Recent Past, Current & Future Analysis for Injection Form by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 9: World Historic Review for Injection Form by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 10: World 15-Year Perspective for Injection Form by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 11: World Recent Past, Current & Future Analysis for Other Dosage Forms by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 12: World Historic Review for Other Dosage Forms by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 13: World 15-Year Perspective for Other Dosage Forms by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 14: World Recent Past, Current & Future Analysis for Cold & Cough Suppressant Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 15: World Historic Review for Cold & Cough Suppressant Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 16: World 15-Year Perspective for Cold & Cough Suppressant Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 17: World Recent Past, Current & Future Analysis for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 18: World Historic Review for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 19: World 15-Year Perspective for Other Applications by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 20: World Recent Past, Current & Future Analysis for Pain Management Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 21: World Historic Review for Pain Management Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 22: World 15-Year Perspective for Pain Management Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 23: World Recent Past, Current & Future Analysis for Diarrhea Suppressant Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 24: World Historic Review for Diarrhea Suppressant Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 25: World 15-Year Perspective for Diarrhea Suppressant Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 26: World Recent Past, Current & Future Analysis for Hospitals & Clinics End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 27: World Historic Review for Hospitals & Clinics End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 28: World 15-Year Perspective for Hospitals & Clinics End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 29: World Recent Past, Current & Future Analysis for Ambulatory Surgery Centers End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 30: World Historic Review for Ambulatory Surgery Centers End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 31: World 15-Year Perspective for Ambulatory Surgery Centers End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 32: World Recent Past, Current & Future Analysis for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 33: World Historic Review for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 34: World 15-Year Perspective for Other End-Uses by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 35: World Recent Past, Current & Future Analysis for Hospital Pharmacies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 36: World Historic Review for Hospital Pharmacies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 37: World 15-Year Perspective for Hospital Pharmacies by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 38: World Recent Past, Current & Future Analysis for Retail Pharmacies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 39: World Historic Review for Retail Pharmacies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 40: World 15-Year Perspective for Retail Pharmacies by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 41: World Recent Past, Current & Future Analysis for Online Pharmacies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 42: World Historic Review for Online Pharmacies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 43: World 15-Year Perspective for Online Pharmacies by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 44: World Recent Past, Current & Future Analysis for Other Distribution Channels by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 45: World Historic Review for Other Distribution Channels by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 46: World 15-Year Perspective for Other Distribution Channels by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030

III. MARKET ANALYSIS

• UNITED STATES
  • Morphine Drugs Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
  • TABLE 47: USA Recent Past, Current & Future Analysis for Morphine Drugs by Dosage Form - Oral Form, Injection Form and Other Dosage Forms - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 48: USA Historic Review for Morphine Drugs by Dosage Form - Oral Form, Injection Form and Other Dosage Forms Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 49: USA 15-Year Perspective for Morphine Drugs by Dosage Form - Percentage Breakdown of Value Sales for Oral Form, Injection Form and Other Dosage Forms for the Years 2015, 2025 & 2030
  • TABLE 50: USA Recent Past, Current & Future Analysis for Morphine Drugs by Application - Cold & Cough Suppressant Application, Other Applications, Pain Management Application and Diarrhea Suppressant Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 51: USA Historic Review for Morphine Drugs by Application - Cold & Cough Suppressant Application, Other Applications, Pain Management Application and Diarrhea Suppressant Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 52: USA 15-Year Perspective for Morphine Drugs by Application - Percentage Breakdown of Value Sales for Cold & Cough Suppressant Application, Other Applications, Pain Management Application and Diarrhea Suppressant Application for the Years 2015, 2025 & 2030
  • TABLE 53: USA Recent Past, Current & Future Analysis for Morphine Drugs by End-Use - Hospitals & Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 54: USA Historic Review for Morphine Drugs by End-Use - Hospitals & Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 55: USA 15-Year Perspective for Morphine Drugs by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2015, 2025 & 2030
  • TABLE 56: USA Recent Past, Current & Future Analysis for Morphine Drugs by Distribution Channel - Hospital Pharmacies, Retail Pharmacies, Online Pharmacies and Other Distribution Channels - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 57: USA Historic Review for Morphine Drugs by Distribution Channel - Hospital Pharmacies, Retail Pharmacies, Online Pharmacies and Other Distribution Channels Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 58: USA 15-Year Perspective for Morphine Drugs by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Retail Pharmacies, Online Pharmacies and Other Distribution Channels for the Years 2015, 2025 & 2030
• CANADA
  • TABLE 59: Canada Recent Past, Current & Future Analysis for Morphine Drugs by Dosage Form - Oral Form, Injection Form and Other Dosage Forms - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 60: Canada Historic Review for Morphine Drugs by Dosage Form - Oral Form, Injection Form and Other Dosage Forms Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 61: Canada 15-Year Perspective for Morphine Drugs by Dosage Form - Percentage Breakdown of Value Sales for Oral Form, Injection Form and Other Dosage Forms for the Years 2015, 2025 & 2030
  • TABLE 62: Canada Recent Past, Current & Future Analysis for Morphine Drugs by Application - Cold & Cough Suppressant Application, Other Applications, Pain Management Application and Diarrhea Suppressant Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 63: Canada Historic Review for Morphine Drugs by Application - Cold & Cough Suppressant Application, Other Applications, Pain Management Application and Diarrhea Suppressant Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 64: Canada 15-Year Perspective for Morphine Drugs by Application - Percentage Breakdown of Value Sales for Cold & Cough Suppressant Application, Other Applications, Pain Management Application and Diarrhea Suppressant Application for the Years 2015, 2025 & 2030
  • TABLE 65: Canada Recent Past, Current & Future Analysis for Morphine Drugs by End-Use - Hospitals & Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 66: Canada Historic Review for Morphine Drugs by End-Use - Hospitals & Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 67: Canada 15-Year Perspective for Morphine Drugs by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2015, 2025 & 2030
  • TABLE 68: Canada Recent Past, Current & Future Analysis for Morphine Drugs by Distribution Channel - Hospital Pharmacies, Retail Pharmacies, Online Pharmacies and Other Distribution Channels - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 69: Canada Historic Review for Morphine Drugs by Distribution Channel - Hospital Pharmacies, Retail Pharmacies, Online Pharmacies and Other Distribution Channels Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 70: Canada 15-Year Perspective for Morphine Drugs by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Retail Pharmacies, Online Pharmacies and Other Distribution Channels for the Years 2015, 2025 & 2030
• JAPAN
  • Morphine Drugs Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
  • TABLE 71: Japan Recent Past, Current & Future Analysis for Morphine Drugs by Dosage Form - Oral Form, Injection Form and Other Dosage Forms - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 72: Japan Historic Review for Morphine Drugs by Dosage Form - Oral Form, Injection Form and Other Dosage Forms Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 73: Japan 15-Year Perspective for Morphine Drugs by Dosage Form - Percentage Breakdown of Value Sales for Oral Form, Injection Form and Other Dosage Forms for the Years 2015, 2025 & 2030
  • TABLE 74: Japan Recent Past, Current & Future Analysis for Morphine Drugs by Application - Cold & Cough Suppressant Application, Other Applications, Pain Management Application and Diarrhea Suppressant Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 75: Japan Historic Review for Morphine Drugs by Application - Cold & Cough Suppressant Application, Other Applications, Pain Management Application and Diarrhea Suppressant Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 76: Japan 15-Year Perspective for Morphine Drugs by Application - Percentage Breakdown of Value Sales for Cold & Cough Suppressant Application, Other Applications, Pain Management Application and Diarrhea Suppressant Application for the Years 2015, 2025 & 2030
  • TABLE 77: Japan Recent Past, Current & Future Analysis for Morphine Drugs by End-Use - Hospitals & Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 78: Japan Historic Review for Morphine Drugs by End-Use - Hospitals & Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 79: Japan 15-Year Perspective for Morphine Drugs by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2015, 2025 & 2030
  • TABLE 80: Japan Recent Past, Current & Future Analysis for Morphine Drugs by Distribution Channel - Hospital Pharmacies, Retail Pharmacies, Online Pharmacies and Other Distribution Channels - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 81: Japan Historic Review for Morphine Drugs by Distribution Channel - Hospital Pharmacies, Retail Pharmacies, Online Pharmacies and Other Distribution Channels Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 82: Japan 15-Year Perspective for Morphine Drugs by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Retail Pharmacies, Online Pharmacies and Other Distribution Channels for the Years 2015, 2025 & 2030
• CHINA
  • Morphine Drugs Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
  • TABLE 83: China Recent Past, Current & Future Analysis for Morphine Drugs by Dosage Form - Oral Form, Injection Form and Other Dosage Forms - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 84: China Historic Review for Morphine Drugs by Dosage Form - Oral Form, Injection Form and Other Dosage Forms Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 85: China 15-Year Perspective for Morphine Drugs by Dosage Form - Percentage Breakdown of Value Sales for Oral Form, Injection Form and Other Dosage Forms for the Years 2015, 2025 & 2030
  • TABLE 86: China Recent Past, Current & Future Analysis for Morphine Drugs by Application - Cold & Cough Suppressant Application, Other Applications, Pain Management Application and Diarrhea Suppressant Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 87: China Historic Review for Morphine Drugs by Application - Cold & Cough Suppressant Application, Other Applications, Pain Management Application and Diarrhea Suppressant Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 88: China 15-Year Perspective for Morphine Drugs by Application - Percentage Breakdown of Value Sales for Cold & Cough Suppressant Application, Other Applications, Pain Management Application and Diarrhea Suppressant Application for the Years 2015, 2025 & 2030
  • TABLE 89: China Recent Past, Current & Future Analysis for Morphine Drugs by End-Use - Hospitals & Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 90: China Historic Review for Morphine Drugs by End-Use - Hospitals & Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 91: China 15-Year Perspective for Morphine Drugs by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2015, 2025 & 2030
  • TABLE 92: China Recent Past, Current & Future Analysis for Morphine Drugs by Distribution Channel - Hospital Pharmacies, Retail Pharmacies, Online Pharmacies and Other Distribution Channels - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 93: China Historic Review for Morphine Drugs by Distribution Channel - Hospital Pharmacies, Retail Pharmacies, Online Pharmacies and Other Distribution Channels Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 94: China 15-Year Perspective for Morphine Drugs by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Retail Pharmacies, Online Pharmacies and Other Distribution Channels for the Years 2015, 2025 & 2030
• EUROPE
  • Morphine Drugs Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
  • TABLE 95: Europe Recent Past, Current & Future Analysis for Morphine Drugs by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 96: Europe Historic Review for Morphine Drugs by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 97: Europe 15-Year Perspective for Morphine Drugs by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2015, 2025 & 2030
  • TABLE 98: Europe Recent Past, Current & Future Analysis for Morphine Drugs by Dosage Form - Oral Form, Injection Form and Other Dosage Forms - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 99: Europe Historic Review for Morphine Drugs by Dosage Form - Oral Form, Injection Form and Other Dosage Forms Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 100: Europe 15-Year Perspective for Morphine Drugs by Dosage Form - Percentage Breakdown of Value Sales for Oral Form, Injection Form and Other Dosage Forms for the Years 2015, 2025 & 2030
  • TABLE 101: Europe Recent Past, Current & Future Analysis for Morphine Drugs by Application - Cold & Cough Suppressant Application, Other Applications, Pain Management Application and Diarrhea Suppressant Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 102: Europe Historic Review for Morphine Drugs by Application - Cold & Cough Suppressant Application, Other Applications, Pain Management Application and Diarrhea Suppressant Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 103: Europe 15-Year Perspective for Morphine Drugs by Application - Percentage Breakdown of Value Sales for Cold & Cough Suppressant Application, Other Applications, Pain Management Application and Diarrhea Suppressant Application for the Years 2015, 2025 & 2030
  • TABLE 104: Europe Recent Past, Current & Future Analysis for Morphine Drugs by End-Use - Hospitals & Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 105: Europe Historic Review for Morphine Drugs by End-Use - Hospitals & Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 106: Europe 15-Year Perspective for Morphine Drugs by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2015, 2025 & 2030
  • TABLE 107: Europe Recent Past, Current & Future Analysis for Morphine Drugs by Distribution Channel - Hospital Pharmacies, Retail Pharmacies, Online Pharmacies and Other Distribution Channels - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 108: Europe Historic Review for Morphine Drugs by Distribution Channel - Hospital Pharmacies, Retail Pharmacies, Online Pharmacies and Other Distribution Channels Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 109: Europe 15-Year Perspective for Morphine Drugs by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Retail Pharmacies, Online Pharmacies and Other Distribution Channels for the Years 2015, 2025 & 2030
• FRANCE
  • Morphine Drugs Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
  • TABLE 110: France Recent Past, Current & Future Analysis for Morphine Drugs by Dosage Form - Oral Form, Injection Form and Other Dosage Forms - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 111: France Historic Review for Morphine Drugs by Dosage Form - Oral Form, Injection Form and Other Dosage Forms Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 112: France 15-Year Perspective for Morphine Drugs by Dosage Form - Percentage Breakdown of Value Sales for Oral Form, Injection Form and Other Dosage Forms for the Years 2015, 2025 & 2030
  • TABLE 113: France Recent Past, Current & Future Analysis for Morphine Drugs by Application - Cold & Cough Suppressant Application, Other Applications, Pain Management Application and Diarrhea Suppressant Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 114: France Historic Review for Morphine Drugs by Application - Cold & Cough Suppressant Application, Other Applications, Pain Management Application and Diarrhea Suppressant Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 115: France 15-Year Perspective for Morphine Drugs by Application - Percentage Breakdown of Value Sales for Cold & Cough Suppressant Application, Other Applications, Pain Management Application and Diarrhea Suppressant Application for the Years 2015, 2025 & 2030
  • TABLE 116: France Recent Past, Current & Future Analysis for Morphine Drugs by End-Use - Hospitals & Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 117: France Historic Review for Morphine Drugs by End-Use - Hospitals & Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 118: France 15-Year Perspective for Morphine Drugs by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2015, 2025 & 2030
  • TABLE 119: France Recent Past, Current & Future Analysis for Morphine Drugs by Distribution Channel - Hospital Pharmacies, Retail Pharmacies, Online Pharmacies and Other Distribution Channels - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 120: France Historic Review for Morphine Drugs by Distribution Channel - Hospital Pharmacies, Retail Pharmacies, Online Pharmacies and Other Distribution Channels Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 121: France 15-Year Perspective for Morphine Drugs by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Retail Pharmacies, Online Pharmacies and Other Distribution Channels for the Years 2015, 2025 & 2030
• GERMANY
  • Morphine Drugs Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
  • TABLE 122: Germany Recent Past, Current & Future Analysis for Morphine Drugs by Dosage Form - Oral Form, Injection Form and Other Dosage Forms - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 123: Germany Historic Review for Morphine Drugs by Dosage Form - Oral Form, Injection Form and Other Dosage Forms Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 124: Germany 15-Year Perspective for Morphine Drugs by Dosage Form - Percentage Breakdown of Value Sales for Oral Form, Injection Form and Other Dosage Forms for the Years 2015, 2025 & 2030
  • TABLE 125: Germany Recent Past, Current & Future Analysis for Morphine Drugs by Application - Cold & Cough Suppressant Application, Other Applications, Pain Management Application and Diarrhea Suppressant Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 126: Germany Historic Review for Morphine Drugs by Application - Cold & Cough Suppressant Application, Other Applications, Pain Management Application and Diarrhea Suppressant Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 127: Germany 15-Year Perspective for Morphine Drugs by Application - Percentage Breakdown of Value Sales for Cold & Cough Suppressant Application, Other Applications, Pain Management Application and Diarrhea Suppressant Application for the Years 2015, 2025 & 2030
  • TABLE 128: Germany Recent Past, Current & Future Analysis for Morphine Drugs by End-Use - Hospitals & Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 129: Germany Historic Review for Morphine Drugs by End-Use - Hospitals & Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 130: Germany 15-Year Perspective for Morphine Drugs by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2015, 2025 & 2030
  • TABLE 131: Germany Recent Past, Current & Future Analysis for Morphine Drugs by Distribution Channel - Hospital Pharmacies, Retail Pharmacies, Online Pharmacies and Other Distribution Channels - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 132: Germany Historic Review for Morphine Drugs by Distribution Channel - Hospital Pharmacies, Retail Pharmacies, Online Pharmacies and Other Distribution Channels Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 133: Germany 15-Year Perspective for Morphine Drugs by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Retail Pharmacies, Online Pharmacies and Other Distribution Channels for the Years 2015, 2025 & 2030
• ITALY
  • TABLE 134: Italy Recent Past, Current & Future Analysis for Morphine Drugs by Dosage Form - Oral Form, Injection Form and Other Dosage Forms - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 135: Italy Historic Review for Morphine Drugs by Dosage Form - Oral Form, Injection Form and Other Dosage Forms Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 136: Italy 15-Year Perspective for Morphine Drugs by Dosage Form - Percentage Breakdown of Value Sales for Oral Form, Injection Form and Other Dosage Forms for the Years 2015, 2025 & 2030
  • TABLE 137: Italy Recent Past, Current & Future Analysis for Morphine Drugs by Application - Cold & Cough Suppressant Application, Other Applications, Pain Management Application and Diarrhea Suppressant Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 138: Italy Historic Review for Morphine Drugs by Application - Cold & Cough Suppressant Application, Other Applications, Pain Management Application and Diarrhea Suppressant Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 139: Italy 15-Year Perspective for Morphine Drugs by Application - Percentage Breakdown of Value Sales for Cold & Cough Suppressant Application, Other Applications, Pain Management Application and Diarrhea Suppressant Application for the Years 2015, 2025 & 2030
  • TABLE 140: Italy Recent Past, Current & Future Analysis for Morphine Drugs by End-Use - Hospitals & Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 141: Italy Historic Review for Morphine Drugs by End-Use - Hospitals & Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 142: Italy 15-Year Perspective for Morphine Drugs by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2015, 2025 & 2030
  • TABLE 143: Italy Recent Past, Current & Future Analysis for Morphine Drugs by Distribution Channel - Hospital Pharmacies, Retail Pharmacies, Online Pharmacies and Other Distribution Channels - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 144: Italy Historic Review for Morphine Drugs by Distribution Channel - Hospital Pharmacies, Retail Pharmacies, Online Pharmacies and Other Distribution Channels Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 145: Italy 15-Year Perspective for Morphine Drugs by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Retail Pharmacies, Online Pharmacies and Other Distribution Channels for the Years 2015, 2025 & 2030
• UNITED KINGDOM
  • Morphine Drugs Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
  • TABLE 146: UK Recent Past, Current & Future Analysis for Morphine Drugs by Dosage Form - Oral Form, Injection Form and Other Dosage Forms - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 147: UK Historic Review for Morphine Drugs by Dosage Form - Oral Form, Injection Form and Other Dosage Forms Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 148: UK 15-Year Perspective for Morphine Drugs by Dosage Form - Percentage Breakdown of Value Sales for Oral Form, Injection Form and Other Dosage Forms for the Years 2015, 2025 & 2030
  • TABLE 149: UK Recent Past, Current & Future Analysis for Morphine Drugs by Application - Cold & Cough Suppressant Application, Other Applications, Pain Management Application and Diarrhea Suppressant Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 150: UK Historic Review for Morphine Drugs by Application - Cold & Cough Suppressant Application, Other Applications, Pain Management Application and Diarrhea Suppressant Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 151: UK 15-Year Perspective for Morphine Drugs by Application - Percentage Breakdown of Value Sales for Cold & Cough Suppressant Application, Other Applications, Pain Management Application and Diarrhea Suppressant Application for the Years 2015, 2025 & 2030
  • TABLE 152: UK Recent Past, Current & Future Analysis for Morphine Drugs by End-Use - Hospitals & Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 153: UK Historic Review for Morphine Drugs by End-Use - Hospitals & Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 154: UK 15-Year Perspective for Morphine Drugs by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2015, 2025 & 2030
  • TABLE 155: UK Recent Past, Current & Future Analysis for Morphine Drugs by Distribution Channel - Hospital Pharmacies, Retail Pharmacies, Online Pharmacies and Other Distribution Channels - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 156: UK Historic Review for Morphine Drugs by Distribution Channel - Hospital Pharmacies, Retail Pharmacies, Online Pharmacies and Other Distribution Channels Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 157: UK 15-Year Perspective for Morphine Drugs by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Retail Pharmacies, Online Pharmacies and Other Distribution Channels for the Years 2015, 2025 & 2030
• SPAIN
  • TABLE 158: Spain Recent Past, Current & Future Analysis for Morphine Drugs by Dosage Form - Oral Form, Injection Form and Other Dosage Forms - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 159: Spain Historic Review for Morphine Drugs by Dosage Form - Oral Form, Injection Form and Other Dosage Forms Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 160: Spain 15-Year Perspective for Morphine Drugs by Dosage Form - Percentage Breakdown of Value Sales for Oral Form, Injection Form and Other Dosage Forms for the Years 2015, 2025 & 2030
  • TABLE 161: Spain Recent Past, Current & Future Analysis for Morphine Drugs by Application - Cold & Cough Suppressant Application, Other Applications, Pain Management Application and Diarrhea Suppressant Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 162: Spain Historic Review for Morphine Drugs by Application - Cold & Cough Suppressant Application, Other Applications, Pain Management Application and Diarrhea Suppressant Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 163: Spain 15-Year Perspective for Morphine Drugs by Application - Percentage Breakdown of Value Sales for Cold & Cough Suppressant Application, Other Applications, Pain Management Application and Diarrhea Suppressant Application for the Years 2015, 2025 & 2030
  • TABLE 164: Spain Recent Past, Current & Future Analysis for Morphine Drugs by End-Use - Hospitals & Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 165: Spain Historic Review for Morphine Drugs by End-Use - Hospitals & Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 166: Spain 15-Year Perspective for Morphine Drugs by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2015, 2025 & 2030
  • TABLE 167: Spain Recent Past, Current & Future Analysis for Morphine Drugs by Distribution Channel - Hospital Pharmacies, Retail Pharmacies, Online Pharmacies and Other Distribution Channels - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 168: Spain Historic Review for Morphine Drugs by Distribution Channel - Hospital Pharmacies, Retail Pharmacies, Online Pharmacies and Other Distribution Channels Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 169: Spain 15-Year Perspective for Morphine Drugs by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Retail Pharmacies, Online Pharmacies and Other Distribution Channels for the Years 2015, 2025 & 2030
• RUSSIA
  • TABLE 170: Russia Recent Past, Current & Future Analysis for Morphine Drugs by Dosage Form - Oral Form, Injection Form and Other Dosage Forms - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 171: Russia Historic Review for Morphine Drugs by Dosage Form - Oral Form, Injection Form and Other Dosage Forms Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 172: Russia 15-Year Perspective for Morphine Drugs by Dosage Form - Percentage Breakdown of Value Sales for Oral Form, Injection Form and Other Dosage Forms for the Years 2015, 2025 & 2030
  • TABLE 173: Russia Recent Past, Current & Future Analysis for Morphine Drugs by Application - Cold & Cough Suppressant Application, Other Applications, Pain Management Application and Diarrhea Suppressant Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 174: Russia Historic Review for Morphine Drugs by Application - Cold & Cough Suppressant Application, Other Applications, Pain Management Application and Diarrhea Suppressant Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 175: Russia 15-Year Perspective for Morphine Drugs by Application - Percentage Breakdown of Value Sales for Cold & Cough Suppressant Application, Other Applications, Pain Management Application and Diarrhea Suppressant Application for the Years 2015, 2025 & 2030
  • TABLE 176: Russia Recent Past, Current & Future Analysis for Morphine Drugs by End-Use - Hospitals & Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 177: Russia Historic Review for Morphine Drugs by End-Use - Hospitals & Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 178: Russia 15-Year Perspective for Morphine Drugs by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2015, 2025 & 2030
  • TABLE 179: Russia Recent Past, Current & Future Analysis for Morphine Drugs by Distribution Channel - Hospital Pharmacies, Retail Pharmacies, Online Pharmacies and Other Distribution Channels - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 180: Russia Historic Review for Morphine Drugs by Distribution Channel - Hospital Pharmacies, Retail Pharmacies, Online Pharmacies and Other Distribution Channels Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 181: Russia 15-Year Perspective for Morphine Drugs by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Retail Pharmacies, Online Pharmacies and Other Distribution Channels for the Years 2015, 2025 & 2030
• REST OF EUROPE
  • TABLE 182: Rest of Europe Recent Past, Current & Future Analysis for Morphine Drugs by Dosage Form - Oral Form, Injection Form and Other Dosage Forms - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 183: Rest of Europe Historic Review for Morphine Drugs by Dosage Form - Oral Form, Injection Form and Other Dosage Forms Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 184: Rest of Europe 15-Year Perspective for Morphine Drugs by Dosage Form - Percentage Breakdown of Value Sales for Oral Form, Injection Form and Other Dosage Forms for the Years 2015, 2025 & 2030
  • TABLE 185: Rest of Europe Recent Past, Current & Future Analysis for Morphine Drugs by Application - Cold & Cough Suppressant Application, Other Applications, Pain Management Application and Diarrhea Suppressant Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 186: Rest of Europe Historic Review for Morphine Drugs by Application - Cold & Cough Suppressant Application, Other Applications, Pain Management Application and Diarrhea Suppressant Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 187: Rest of Europe 15-Year Perspective for Morphine Drugs by Application - Percentage Breakdown of Value Sales for Cold & Cough Suppressant Application, Other Applications, Pain Management Application and Diarrhea Suppressant Application for the Years 2015, 2025 & 2030
  • TABLE 188: Rest of Europe Recent Past, Current & Future Analysis for Morphine Drugs by End-Use - Hospitals & Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 189: Rest of Europe Historic Review for Morphine Drugs by End-Use - Hospitals & Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 190: Rest of Europe 15-Year Perspective for Morphine Drugs by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2015, 2025 & 2030
  • TABLE 191: Rest of Europe Recent Past, Current & Future Analysis for Morphine Drugs by Distribution Channel - Hospital Pharmacies, Retail Pharmacies, Online Pharmacies and Other Distribution Channels - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 192: Rest of Europe Historic Review for Morphine Drugs by Distribution Channel - Hospital Pharmacies, Retail Pharmacies, Online Pharmacies and Other Distribution Channels Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 193: Rest of Europe 15-Year Perspective for Morphine Drugs by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Retail Pharmacies, Online Pharmacies and Other Distribution Channels for the Years 2015, 2025 & 2030
• ASIA-PACIFIC
  • Morphine Drugs Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
  • TABLE 194: Asia-Pacific Recent Past, Current & Future Analysis for Morphine Drugs by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 195: Asia-Pacific Historic Review for Morphine Drugs by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 196: Asia-Pacific 15-Year Perspective for Morphine Drugs by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2015, 2025 & 2030
  • TABLE 197: Asia-Pacific Recent Past, Current & Future Analysis for Morphine Drugs by Dosage Form - Oral Form, Injection Form and Other Dosage Forms - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 198: Asia-Pacific Historic Review for Morphine Drugs by Dosage Form - Oral Form, Injection Form and Other Dosage Forms Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 199: Asia-Pacific 15-Year Perspective for Morphine Drugs by Dosage Form - Percentage Breakdown of Value Sales for Oral Form, Injection Form and Other Dosage Forms for the Years 2015, 2025 & 2030
  • TABLE 200: Asia-Pacific Recent Past, Current & Future Analysis for Morphine Drugs by Application - Cold & Cough Suppressant Application, Other Applications, Pain Management Application and Diarrhea Suppressant Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 201: Asia-Pacific Historic Review for Morphine Drugs by Application - Cold & Cough Suppressant Application, Other Applications, Pain Management Application and Diarrhea Suppressant Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 202: Asia-Pacific 15-Year Perspective for Morphine Drugs by Application - Percentage Breakdown of Value Sales for Cold & Cough Suppressant Application, Other Applications, Pain Management Application and Diarrhea Suppressant Application for the Years 2015, 2025 & 2030
  • TABLE 203: Asia-Pacific Recent Past, Current & Future Analysis for Morphine Drugs by End-Use - Hospitals & Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 204: Asia-Pacific Historic Review for Morphine Drugs by End-Use - Hospitals & Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 205: Asia-Pacific 15-Year Perspective for Morphine Drugs by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2015, 2025 & 2030
  • TABLE 206: Asia-Pacific Recent Past, Current & Future Analysis for Morphine Drugs by Distribution Channel - Hospital Pharmacies, Retail Pharmacies, Online Pharmacies and Other Distribution Channels - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 207: Asia-Pacific Historic Review for Morphine Drugs by Distribution Channel - Hospital Pharmacies, Retail Pharmacies, Online Pharmacies and Other Distribution Channels Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 208: Asia-Pacific 15-Year Perspective for Morphine Drugs by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Retail Pharmacies, Online Pharmacies and Other Distribution Channels for the Years 2015, 2025 & 2030
• AUSTRALIA
  • Morphine Drugs Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2025 (E)
  • TABLE 209: Australia Recent Past, Current & Future Analysis for Morphine Drugs by Dosage Form - Oral Form, Injection Form and Other Dosage Forms - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 210: Australia Historic Review for Morphine Drugs by Dosage Form - Oral Form, Injection Form and Other Dosage Forms Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 211: Australia 15-Year Perspective for Morphine Drugs by Dosage Form - Percentage Breakdown of Value Sales for Oral Form, Injection Form and Other Dosage Forms for the Years 2015, 2025 & 2030
  • TABLE 212: Australia Recent Past, Current & Future Analysis for Morphine Drugs by Application - Cold & Cough Suppressant Application, Other Applications, Pain Management Application and Diarrhea Suppressant Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 213: Australia Historic Review for Morphine Drugs by Application - Cold & Cough Suppressant Application, Other Applications, Pain Management Application and Diarrhea Suppressant Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 214: Australia 15-Year Perspective for Morphine Drugs by Application - Percentage Breakdown of Value Sales for Cold & Cough Suppressant Application, Other Applications, Pain Management Application and Diarrhea Suppressant Application for the Years 2015, 2025 & 2030
  • TABLE 215: Australia Recent Past, Current & Future Analysis for Morphine Drugs by End-Use - Hospitals & Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 216: Australia Historic Review for Morphine Drugs by End-Use - Hospitals & Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 217: Australia 15-Year Perspective for Morphine Drugs by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2015, 2025 & 2030
  • TABLE 218: Australia Recent Past, Current & Future Analysis for Morphine Drugs by Distribution Channel - Hospital Pharmacies, Retail Pharmacies, Online Pharmacies and Other Distribution Channels - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 219: Australia Historic Review for Morphine Drugs by Distribution Channel - Hospital Pharmacies, Retail Pharmacies, Online Pharmacies and Other Distribution Channels Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 220: Australia 15-Year Perspective for Morphine Drugs by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Retail Pharmacies, Online Pharmacies and Other Distribution Channels for the Years 2015, 2025 & 2030
• INDIA
  • Morphine Drugs Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2025 (E)
  • TABLE 221: India Recent Past, Current & Future Analysis for Morphine Drugs by Dosage Form - Oral Form, Injection Form and Other Dosage Forms - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 222: India Historic Review for Morphine Drugs by Dosage Form - Oral Form, Injection Form and Other Dosage Forms Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 223: India 15-Year Perspective for Morphine Drugs by Dosage Form - Percentage Breakdown of Value Sales for Oral Form, Injection Form and Other Dosage Forms for the Years 2015, 2025 & 2030
  • TABLE 224: India Recent Past, Current & Future Analysis for Morphine Drugs by Application - Cold & Cough Suppressant Application, Other Applications, Pain Management Application and Diarrhea Suppressant Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 225: India Historic Review for Morphine Drugs by Application - Cold & Cough Suppressant Application, Other Applications, Pain Management Application and Diarrhea Suppressant Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 226: India 15-Year Perspective for Morphine Drugs by Application - Percentage Breakdown of Value Sales for Cold & Cough Suppressant Application, Other Applications, Pain Management Application and Diarrhea Suppressant Application for the Years 2015, 2025 & 2030
  • TABLE 227: India Recent Past, Current & Future Analysis for Morphine Drugs by End-Use - Hospitals & Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 228: India Historic Review for Morphine Drugs by End-Use - Hospitals & Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 229: India 15-Year Perspective for Morphine Drugs by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2015, 2025 & 2030
  • TABLE 230: India Recent Past, Current & Future Analysis for Morphine Drugs by Distribution Channel - Hospital Pharmacies, Retail Pharmacies, Online Pharmacies and Other Distribution Channels - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 231: India Historic Review for Morphine Drugs by Distribution Channel - Hospital Pharmacies, Retail Pharmacies, Online Pharmacies and Other Distribution Channels Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 232: India 15-Year Perspective for Morphine Drugs by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Retail Pharmacies, Online Pharmacies and Other Distribution Channels for the Years 2015, 2025 & 2030
• SOUTH KOREA
  • TABLE 233: South Korea Recent Past, Current & Future Analysis for Morphine Drugs by Dosage Form - Oral Form, Injection Form and Other Dosage Forms - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 234: South Korea Historic Review for Morphine Drugs by Dosage Form - Oral Form, Injection Form and Other Dosage Forms Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 235: South Korea 15-Year Perspective for Morphine Drugs by Dosage Form - Percentage Breakdown of Value Sales for Oral Form, Injection Form and Other Dosage Forms for the Years 2015, 2025 & 2030
  • TABLE 236: South Korea Recent Past, Current & Future Analysis for Morphine Drugs by Application - Cold & Cough Suppressant Application, Other Applications, Pain Management Application and Diarrhea Suppressant Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 237: South Korea Historic Review for Morphine Drugs by Application - Cold & Cough Suppressant Application, Other Applications, Pain Management Application and Diarrhea Suppressant Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 238: South Korea 15-Year Perspective for Morphine Drugs by Application - Percentage Breakdown of Value Sales for Cold & Cough Suppressant Application, Other Applications, Pain Management Application and Diarrhea Suppressant Application for the Years 2015, 2025 & 2030
  • TABLE 239: South Korea Recent Past, Current & Future Analysis for Morphine Drugs by End-Use - Hospitals & Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 240: South Korea Historic Review for Morphine Drugs by End-Use - Hospitals & Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 241: South Korea 15-Year Perspective for Morphine Drugs by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2015, 2025 & 2030
  • TABLE 242: South Korea Recent Past, Current & Future Analysis for Morphine Drugs by Distribution Channel - Hospital Pharmacies, Retail Pharmacies, Online Pharmacies and Other Distribution Channels - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 243: South Korea Historic Review for Morphine Drugs by Distribution Channel - Hospital Pharmacies, Retail Pharmacies, Online Pharmacies and Other Distribution Channels Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 244: South Korea 15-Year Perspective for Morphine Drugs by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Retail Pharmacies, Online Pharmacies and Other Distribution Channels for the Years 2015, 2025 & 2030
• REST OF ASIA-PACIFIC
  • TABLE 245: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Morphine Drugs by Dosage Form - Oral Form, Injection Form and Other Dosage Forms - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 246: Rest of Asia-Pacific Historic Review for Morphine Drugs by Dosage Form - Oral Form, Injection Form and Other Dosage Forms Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 247: Rest of Asia-Pacific 15-Year Perspective for Morphine Drugs by Dosage Form - Percentage Breakdown of Value Sales for Oral Form, Injection Form and Other Dosage Forms for the Years 2015, 2025 & 2030
  • TABLE 248: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Morphine Drugs by Application - Cold & Cough Suppressant Application, Other Applications, Pain Management Application and Diarrhea Suppressant Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 249: Rest of Asia-Pacific Historic Review for Morphine Drugs by Application - Cold & Cough Suppressant Application, Other Applications, Pain Management Application and Diarrhea Suppressant Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 250: Rest of Asia-Pacific 15-Year Perspective for Morphine Drugs by Application - Percentage Breakdown of Value Sales for Cold & Cough Suppressant Application, Other Applications, Pain Management Application and Diarrhea Suppressant Application for the Years 2015, 2025 & 2030
  • TABLE 251: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Morphine Drugs by End-Use - Hospitals & Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 252: Rest of Asia-Pacific Historic Review for Morphine Drugs by End-Use - Hospitals & Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 253: Rest of Asia-Pacific 15-Year Perspective for Morphine Drugs by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2015, 2025 & 2030
  • TABLE 254: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Morphine Drugs by Distribution Channel - Hospital Pharmacies, Retail Pharmacies, Online Pharmacies and Other Distribution Channels - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 255: Rest of Asia-Pacific Historic Review for Morphine Drugs by Distribution Channel - Hospital Pharmacies, Retail Pharmacies, Online Pharmacies and Other Distribution Channels Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 256: Rest of Asia-Pacific 15-Year Perspective for Morphine Drugs by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Retail Pharmacies, Online Pharmacies and Other Distribution Channels for the Years 2015, 2025 & 2030
• LATIN AMERICA
  • Morphine Drugs Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2025 (E)
  • TABLE 257: Latin America Recent Past, Current & Future Analysis for Morphine Drugs by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 258: Latin America Historic Review for Morphine Drugs by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 259: Latin America 15-Year Perspective for Morphine Drugs by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2015, 2025 & 2030
  • TABLE 260: Latin America Recent Past, Current & Future Analysis for Morphine Drugs by Dosage Form - Oral Form, Injection Form and Other Dosage Forms - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 261: Latin America Historic Review for Morphine Drugs by Dosage Form - Oral Form, Injection Form and Other Dosage Forms Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 262: Latin America 15-Year Perspective for Morphine Drugs by Dosage Form - Percentage Breakdown of Value Sales for Oral Form, Injection Form and Other Dosage Forms for the Years 2015, 2025 & 2030
  • TABLE 263: Latin America Recent Past, Current & Future Analysis for Morphine Drugs by Application - Cold & Cough Suppressant Application, Other Applications, Pain Management Application and Diarrhea Suppressant Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 264: Latin America Historic Review for Morphine Drugs by Application - Cold & Cough Suppressant Application, Other Applications, Pain Management Application and Diarrhea Suppressant Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 265: Latin America 15-Year Perspective for Morphine Drugs by Application - Percentage Breakdown of Value Sales for Cold & Cough Suppressant Application, Other Applications, Pain Management Application and Diarrhea Suppressant Application for the Years 2015, 2025 & 2030
  • TABLE 266: Latin America Recent Past, Current & Future Analysis for Morphine Drugs by End-Use - Hospitals & Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 267: Latin America Historic Review for Morphine Drugs by End-Use - Hospitals & Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 268: Latin America 15-Year Perspective for Morphine Drugs by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2015, 2025 & 2030
  • TABLE 269: Latin America Recent Past, Current & Future Analysis for Morphine Drugs by Distribution Channel - Hospital Pharmacies, Retail Pharmacies, Online Pharmacies and Other Distribution Channels - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 270: Latin America Historic Review for Morphine Drugs by Distribution Channel - Hospital Pharmacies, Retail Pharmacies, Online Pharmacies and Other Distribution Channels Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 271: Latin America 15-Year Perspective for Morphine Drugs by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Retail Pharmacies, Online Pharmacies and Other Distribution Channels for the Years 2015, 2025 & 2030
• ARGENTINA
  • TABLE 272: Argentina Recent Past, Current & Future Analysis for Morphine Drugs by Dosage Form - Oral Form, Injection Form and Other Dosage Forms - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 273: Argentina Historic Review for Morphine Drugs by Dosage Form - Oral Form, Injection Form and Other Dosage Forms Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 274: Argentina 15-Year Perspective for Morphine Drugs by Dosage Form - Percentage Breakdown of Value Sales for Oral Form, Injection Form and Other Dosage Forms for the Years 2015, 2025 & 2030
  • TABLE 275: Argentina Recent Past, Current & Future Analysis for Morphine Drugs by Application - Cold & Cough Suppressant Application, Other Applications, Pain Management Application and Diarrhea Suppressant Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 276: Argentina Historic Review for Morphine Drugs by Application - Cold & Cough Suppressant Application, Other Applications, Pain Management Application and Diarrhea Suppressant Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 277: Argentina 15-Year Perspective for Morphine Drugs by Application - Percentage Breakdown of Value Sales for Cold & Cough Suppressant Application, Other Applications, Pain Management Application and Diarrhea Suppressant Application for the Years 2015, 2025 & 2030
  • TABLE 278: Argentina Recent Past, Current & Future Analysis for Morphine Drugs by End-Use - Hospitals & Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 279: Argentina Historic Review for Morphine Drugs by End-Use - Hospitals & Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 280: Argentina 15-Year Perspective for Morphine Drugs by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2015, 2025 & 2030
  • TABLE 281: Argentina Recent Past, Current & Future Analysis for Morphine Drugs by Distribution Channel - Hospital Pharmacies, Retail Pharmacies, Online Pharmacies and Other Distribution Channels - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 282: Argentina Historic Review for Morphine Drugs by Distribution Channel - Hospital Pharmacies, Retail Pharmacies, Online Pharmacies and Other Distribution Channels Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 283: Argentina 15-Year Perspective for Morphine Drugs by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Retail Pharmacies, Online Pharmacies and Other Distribution Channels for the Years 2015, 2025 & 2030
• BRAZIL
  • TABLE 284: Brazil Recent Past, Current & Future Analysis for Morphine Drugs by Dosage Form - Oral Form, Injection Form and Other Dosage Forms - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 285: Brazil Historic Review for Morphine Drugs by Dosage Form - Oral Form, Injection Form and Other Dosage Forms Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 286: Brazil 15-Year Perspective for Morphine Drugs by Dosage Form - Percentage Breakdown of Value Sales for Oral Form, Injection Form and Other Dosage Forms for the Years 2015, 2025 & 2030
  • TABLE 287: Brazil Recent Past, Current & Future Analysis for Morphine Drugs by Application - Cold & Cough Suppressant Application, Other Applications, Pain Management Application and Diarrhea Suppressant Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 288: Brazil Historic Review for Morphine Drugs by Application - Cold & Cough Suppressant Application, Other Applications, Pain Management Application and Diarrhea Suppressant Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 289: Brazil 15-Year Perspective for Morphine Drugs by Application - Percentage Breakdown of Value Sales for Cold & Cough Suppressant Application, Other Applications, Pain Management Application and Diarrhea Suppressant Application for the Years 2015, 2025 & 2030
  • TABLE 290: Brazil Recent Past, Current & Future Analysis for Morphine Drugs by End-Use - Hospitals & Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 291: Brazil Historic Review for Morphine Drugs by End-Use - Hospitals & Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 292: Brazil 15-Year Perspective for Morphine Drugs by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2015, 2025 & 2030
  • TABLE 293: Brazil Recent Past, Current & Future Analysis for Morphine Drugs by Distribution Channel - Hospital Pharmacies, Retail Pharmacies, Online Pharmacies and Other Distribution Channels - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 294: Brazil Historic Review for Morphine Drugs by Distribution Channel - Hospital Pharmacies, Retail Pharmacies, Online Pharmacies and Other Distribution Channels Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 295: Brazil 15-Year Perspective for Morphine Drugs by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Retail Pharmacies, Online Pharmacies and Other Distribution Channels for the Years 2015, 2025 & 2030
• MEXICO
  • TABLE 296: Mexico Recent Past, Current & Future Analysis for Morphine Drugs by Dosage Form - Oral Form, Injection Form and Other Dosage Forms - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 297: Mexico Historic Review for Morphine Drugs by Dosage Form - Oral Form, Injection Form and Other Dosage Forms Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 298: Mexico 15-Year Perspective for Morphine Drugs by Dosage Form - Percentage Breakdown of Value Sales for Oral Form, Injection Form and Other Dosage Forms for the Years 2015, 2025 & 2030
  • TABLE 299: Mexico Recent Past, Current & Future Analysis for Morphine Drugs by Application - Cold & Cough Suppressant Application, Other Applications, Pain Management Application and Diarrhea Suppressant Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 300: Mexico Historic Review for Morphine Drugs by Application - Cold & Cough Suppressant Application, Other Applications, Pain Management Application and Diarrhea Suppressant Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 301: Mexico 15-Year Perspective for Morphine Drugs by Application - Percentage Breakdown of Value Sales for Cold & Cough Suppressant Application, Other Applications, Pain Management Application and Diarrhea Suppressant Application for the Years 2015, 2025 & 2030
  • TABLE 302: Mexico Recent Past, Current & Future Analysis for Morphine Drugs by End-Use - Hospitals & Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 303: Mexico Historic Review for Morphine Drugs by End-Use - Hospitals & Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 304: Mexico 15-Year Perspective for Morphine Drugs by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2015, 2025 & 2030
  • TABLE 305: Mexico Recent Past, Current & Future Analysis for Morphine Drugs by Distribution Channel - Hospital Pharmacies, Retail Pharmacies, Online Pharmacies and Other Distribution Channels - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 306: Mexico Historic Review for Morphine Drugs by Distribution Channel - Hospital Pharmacies, Retail Pharmacies, Online Pharmacies and Other Distribution Channels Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 307: Mexico 15-Year Perspective for Morphine Drugs by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Retail Pharmacies, Online Pharmacies and Other Distribution Channels for the Years 2015, 2025 & 2030
• REST OF LATIN AMERICA
  • TABLE 308: Rest of Latin America Recent Past, Current & Future Analysis for Morphine Drugs by Dosage Form - Oral Form, Injection Form and Other Dosage Forms - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 309: Rest of Latin America Historic Review for Morphine Drugs by Dosage Form - Oral Form, Injection Form and Other Dosage Forms Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 310: Rest of Latin America 15-Year Perspective for Morphine Drugs by Dosage Form - Percentage Breakdown of Value Sales for Oral Form, Injection Form and Other Dosage Forms for the Years 2015, 2025 & 2030
  • TABLE 311: Rest of Latin America Recent Past, Current & Future Analysis for Morphine Drugs by Application - Cold & Cough Suppressant Application, Other Applications, Pain Management Application and Diarrhea Suppressant Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 312: Rest of Latin America Historic Review for Morphine Drugs by Application - Cold & Cough Suppressant Application, Other Applications, Pain Management Application and Diarrhea Suppressant Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 313: Rest of Latin America 15-Year Perspective for Morphine Drugs by Application - Percentage Breakdown of Value Sales for Cold & Cough Suppressant Application, Other Applications, Pain Management Application and Diarrhea Suppressant Application for the Years 2015, 2025 & 2030
  • TABLE 314: Rest of Latin America Recent Past, Current & Future Analysis for Morphine Drugs by End-Use - Hospitals & Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 315: Rest of Latin America Historic Review for Morphine Drugs by End-Use - Hospitals & Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 316: Rest of Latin America 15-Year Perspective for Morphine Drugs by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2015, 2025 & 2030
  • TABLE 317: Rest of Latin America Recent Past, Current & Future Analysis for Morphine Drugs by Distribution Channel - Hospital Pharmacies, Retail Pharmacies, Online Pharmacies and Other Distribution Channels - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 318: Rest of Latin America Historic Review for Morphine Drugs by Distribution Channel - Hospital Pharmacies, Retail Pharmacies, Online Pharmacies and Other Distribution Channels Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 319: Rest of Latin America 15-Year Perspective for Morphine Drugs by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Retail Pharmacies, Online Pharmacies and Other Distribution Channels for the Years 2015, 2025 & 2030
• MIDDLE EAST
  • Morphine Drugs Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2025 (E)
  • TABLE 320: Middle East Recent Past, Current & Future Analysis for Morphine Drugs by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 321: Middle East Historic Review for Morphine Drugs by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 322: Middle East 15-Year Perspective for Morphine Drugs by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2015, 2025 & 2030
  • TABLE 323: Middle East Recent Past, Current & Future Analysis for Morphine Drugs by Dosage Form - Oral Form, Injection Form and Other Dosage Forms - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 324: Middle East Historic Review for Morphine Drugs by Dosage Form - Oral Form, Injection Form and Other Dosage Forms Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 325: Middle East 15-Year Perspective for Morphine Drugs by Dosage Form - Percentage Breakdown of Value Sales for Oral Form, Injection Form and Other Dosage Forms for the Years 2015, 2025 & 2030
  • TABLE 326: Middle East Recent Past, Current & Future Analysis for Morphine Drugs by Application - Cold & Cough Suppressant Application, Other Applications, Pain Management Application and Diarrhea Suppressant Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 327: Middle East Historic Review for Morphine Drugs by Application - Cold & Cough Suppressant Application, Other Applications, Pain Management Application and Diarrhea Suppressant Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 328: Middle East 15-Year Perspective for Morphine Drugs by Application - Percentage Breakdown of Value Sales for Cold & Cough Suppressant Application, Other Applications, Pain Management Application and Diarrhea Suppressant Application for the Years 2015, 2025 & 2030
  • TABLE 329: Middle East Recent Past, Current & Future Analysis for Morphine Drugs by End-Use - Hospitals & Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 330: Middle East Historic Review for Morphine Drugs by End-Use - Hospitals & Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 331: Middle East 15-Year Perspective for Morphine Drugs by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2015, 2025 & 2030
  • TABLE 332: Middle East Recent Past, Current & Future Analysis for Morphine Drugs by Distribution Channel - Hospital Pharmacies, Retail Pharmacies, Online Pharmacies and Other Distribution Channels - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 333: Middle East Historic Review for Morphine Drugs by Distribution Channel - Hospital Pharmacies, Retail Pharmacies, Online Pharmacies and Other Distribution Channels Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 334: Middle East 15-Year Perspective for Morphine Drugs by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Retail Pharmacies, Online Pharmacies and Other Distribution Channels for the Years 2015, 2025 & 2030
• IRAN
  • TABLE 335: Iran Recent Past, Current & Future Analysis for Morphine Drugs by Dosage Form - Oral Form, Injection Form and Other Dosage Forms - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 336: Iran Historic Review for Morphine Drugs by Dosage Form - Oral Form, Injection Form and Other Dosage Forms Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 337: Iran 15-Year Perspective for Morphine Drugs by Dosage Form - Percentage Breakdown of Value Sales for Oral Form, Injection Form and Other Dosage Forms for the Years 2015, 2025 & 2030
  • TABLE 338: Iran Recent Past, Current & Future Analysis for Morphine Drugs by Application - Cold & Cough Suppressant Application, Other Applications, Pain Management Application and Diarrhea Suppressant Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 339: Iran Historic Review for Morphine Drugs by Application - Cold & Cough Suppressant Application, Other Applications, Pain Management Application and Diarrhea Suppressant Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 340: Iran 15-Year Perspective for Morphine Drugs by Application - Percentage Breakdown of Value Sales for Cold & Cough Suppressant Application, Other Applications, Pain Management Application and Diarrhea Suppressant Application for the Years 2015, 2025 & 2030
  • TABLE 341: Iran Recent Past, Current & Future Analysis for Morphine Drugs by End-Use - Hospitals & Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 342: Iran Historic Review for Morphine Drugs by End-Use - Hospitals & Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 343: Iran 15-Year Perspective for Morphine Drugs by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2015, 2025 & 2030
  • TABLE 344: Iran Recent Past, Current & Future Analysis for Morphine Drugs by Distribution Channel - Hospital Pharmacies, Retail Pharmacies, Online Pharmacies and Other Distribution Channels - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 345: Iran Historic Review for Morphine Drugs by Distribution Channel - Hospital Pharmacies, Retail Pharmacies, Online Pharmacies and Other Distribution Channels Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 346: Iran 15-Year Perspective for Morphine Drugs by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Retail Pharmacies, Online Pharmacies and Other Distribution Channels for the Years 2015, 2025 & 2030
• ISRAEL
  • TABLE 347: Israel Recent Past, Current & Future Analysis for Morphine Drugs by Dosage Form - Oral Form, Injection Form and Other Dosage Forms - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 348: Israel Historic Review for Morphine Drugs by Dosage Form - Oral Form, Injection Form and Other Dosage Forms Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 349: Israel 15-Year Perspective for Morphine Drugs by Dosage Form - Percentage Breakdown of Value Sales for Oral Form, Injection Form and Other Dosage Forms for the Years 2015, 2025 & 2030
  • TABLE 350: Israel Recent Past, Current & Future Analysis for Morphine Drugs by Application - Cold & Cough Suppressant Application, Other Applications, Pain Management Application and Diarrhea Suppressant Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 351: Israel Historic Review for Morphine Drugs by Application - Cold & Cough Suppressant Application, Other Applications, Pain Management Application and Diarrhea Suppressant Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 352: Israel 15-Year Perspective for Morphine Drugs by Application - Percentage Breakdown of Value Sales for Cold & Cough Suppressant Application, Other Applications, Pain Management Application and Diarrhea Suppressant Application for the Years 2015, 2025 & 2030
  • TABLE 353: Israel Recent Past, Current & Future Analysis for Morphine Drugs by End-Use - Hospitals & Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 354: Israel Historic Review for Morphine Drugs by End-Use - Hospitals & Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 355: Israel 15-Year Perspective for Morphine Drugs by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2015, 2025 & 2030
  • TABLE 356: Israel Recent Past, Current & Future Analysis for Morphine Drugs by Distribution Channel - Hospital Pharmacies, Retail Pharmacies, Online Pharmacies and Other Distribution Channels - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 357: Israel Historic Review for Morphine Drugs by Distribution Channel - Hospital Pharmacies, Retail Pharmacies, Online Pharmacies and Other Distribution Channels Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 358: Israel 15-Year Perspective for Morphine Drugs by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Retail Pharmacies, Online Pharmacies and Other Distribution Channels for the Years 2015, 2025 & 2030
• SAUDI ARABIA
  • TABLE 359: Saudi Arabia Recent Past, Current & Future Analysis for Morphine Drugs by Dosage Form - Oral Form, Injection Form and Other Dosage Forms - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 360: Saudi Arabia Historic Review for Morphine Drugs by Dosage Form - Oral Form, Injection Form and Other Dosage Forms Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 361: Saudi Arabia 15-Year Perspective for Morphine Drugs by Dosage Form - Percentage Breakdown of Value Sales for Oral Form, Injection Form and Other Dosage Forms for the Years 2015, 2025 & 2030
  • TABLE 362: Saudi Arabia Recent Past, Current & Future Analysis for Morphine Drugs by Application - Cold & Cough Suppressant Application, Other Applications, Pain Management Application and Diarrhea Suppressant Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 363: Saudi Arabia Historic Review for Morphine Drugs by Application - Cold & Cough Suppressant Application, Other Applications, Pain Management Application and Diarrhea Suppressant Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 364: Saudi Arabia 15-Year Perspective for Morphine Drugs by Application - Percentage Breakdown of Value Sales for Cold & Cough Suppressant Application, Other Applications, Pain Management Application and Diarrhea Suppressant Application for the Years 2015, 2025 & 2030
  • TABLE 365: Saudi Arabia Recent Past, Current & Future Analysis for Morphine Drugs by End-Use - Hospitals & Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 366: Saudi Arabia Historic Review for Morphine Drugs by End-Use - Hospitals & Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 367: Saudi Arabia 15-Year Perspective for Morphine Drugs by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2015, 2025 & 2030
  • TABLE 368: Saudi Arabia Recent Past, Current & Future Analysis for Morphine Drugs by Distribution Channel - Hospital Pharmacies, Retail Pharmacies, Online Pharmacies and Other Distribution Channels - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 369: Saudi Arabia Historic Review for Morphine Drugs by Distribution Channel - Hospital Pharmacies, Retail Pharmacies, Online Pharmacies and Other Distribution Channels Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 370: Saudi Arabia 15-Year Perspective for Morphine Drugs by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Retail Pharmacies, Online Pharmacies and Other Distribution Channels for the Years 2015, 2025 & 2030
• UNITED ARAB EMIRATES
  • TABLE 371: UAE Recent Past, Current & Future Analysis for Morphine Drugs by Dosage Form - Oral Form, Injection Form and Other Dosage Forms - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 372: UAE Historic Review for Morphine Drugs by Dosage Form - Oral Form, Injection Form and Other Dosage Forms Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 373: UAE 15-Year Perspective for Morphine Drugs by Dosage Form - Percentage Breakdown of Value Sales for Oral Form, Injection Form and Other Dosage Forms for the Years 2015, 2025 & 2030
  • TABLE 374: UAE Recent Past, Current & Future Analysis for Morphine Drugs by Application - Cold & Cough Suppressant Application, Other Applications, Pain Management Application and Diarrhea Suppressant Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 375: UAE Historic Review for Morphine Drugs by Application - Cold & Cough Suppressant Application, Other Applications, Pain Management Application and Diarrhea Suppressant Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 376: UAE 15-Year Perspective for Morphine Drugs by Application - Percentage Breakdown of Value Sales for Cold & Cough Suppressant Application, Other Applications, Pain Management Application and Diarrhea Suppressant Application for the Years 2015, 2025 & 2030
  • TABLE 377: UAE Recent Past, Current & Future Analysis for Morphine Drugs by End-Use - Hospitals & Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 378: UAE Historic Review for Morphine Drugs by End-Use - Hospitals & Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 379: UAE 15-Year Perspective for Morphine Drugs by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2015, 2025 & 2030
  • TABLE 380: UAE Recent Past, Current & Future Analysis for Morphine Drugs by Distribution Channel - Hospital Pharmacies, Retail Pharmacies, Online Pharmacies and Other Distribution Channels - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 381: UAE Historic Review for Morphine Drugs by Distribution Channel - Hospital Pharmacies, Retail Pharmacies, Online Pharmacies and Other Distribution Channels Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 382: UAE 15-Year Perspective for Morphine Drugs by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Retail Pharmacies, Online Pharmacies and Other Distribution Channels for the Years 2015, 2025 & 2030
• REST OF MIDDLE EAST
  • TABLE 383: Rest of Middle East Recent Past, Current & Future Analysis for Morphine Drugs by Dosage Form - Oral Form, Injection Form and Other Dosage Forms - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 384: Rest of Middle East Historic Review for Morphine Drugs by Dosage Form - Oral Form, Injection Form and Other Dosage Forms Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 385: Rest of Middle East 15-Year Perspective for Morphine Drugs by Dosage Form - Percentage Breakdown of Value Sales for Oral Form, Injection Form and Other Dosage Forms for the Years 2015, 2025 & 2030
  • TABLE 386: Rest of Middle East Recent Past, Current & Future Analysis for Morphine Drugs by Application - Cold & Cough Suppressant Application, Other Applications, Pain Management Application and Diarrhea Suppressant Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 387: Rest of Middle East Historic Review for Morphine Drugs by Application - Cold & Cough Suppressant Application, Other Applications, Pain Management Application and Diarrhea Suppressant Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 388: Rest of Middle East 15-Year Perspective for Morphine Drugs by Application - Percentage Breakdown of Value Sales for Cold & Cough Suppressant Application, Other Applications, Pain Management Application and Diarrhea Suppressant Application for the Years 2015, 2025 & 2030
  • TABLE 389: Rest of Middle East Recent Past, Current & Future Analysis for Morphine Drugs by End-Use - Hospitals & Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 390: Rest of Middle East Historic Review for Morphine Drugs by End-Use - Hospitals & Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 391: Rest of Middle East 15-Year Perspective for Morphine Drugs by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2015, 2025 & 2030
  • TABLE 392: Rest of Middle East Recent Past, Current & Future Analysis for Morphine Drugs by Distribution Channel - Hospital Pharmacies, Retail Pharmacies, Online Pharmacies and Other Distribution Channels - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 393: Rest of Middle East Historic Review for Morphine Drugs by Distribution Channel - Hospital Pharmacies, Retail Pharmacies, Online Pharmacies and Other Distribution Channels Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 394: Rest of Middle East 15-Year Perspective for Morphine Drugs by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Retail Pharmacies, Online Pharmacies and Other Distribution Channels for the Years 2015, 2025 & 2030
• AFRICA
  • Morphine Drugs Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2025 (E)
  • TABLE 395: Africa Recent Past, Current & Future Analysis for Morphine Drugs by Dosage Form - Oral Form, Injection Form and Other Dosage Forms - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 396: Africa Historic Review for Morphine Drugs by Dosage Form - Oral Form, Injection Form and Other Dosage Forms Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 397: Africa 15-Year Perspective for Morphine Drugs by Dosage Form - Percentage Breakdown of Value Sales for Oral Form, Injection Form and Other Dosage Forms for the Years 2015, 2025 & 2030
  • TABLE 398: Africa Recent Past, Current & Future Analysis for Morphine Drugs by Application - Cold & Cough Suppressant Application, Other Applications, Pain Management Application and Diarrhea Suppressant Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 399: Africa Historic Review for Morphine Drugs by Application - Cold & Cough Suppressant Application, Other Applications, Pain Management Application and Diarrhea Suppressant Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 400: Africa 15-Year Perspective for Morphine Drugs by Application - Percentage Breakdown of Value Sales for Cold & Cough Suppressant Application, Other Applications, Pain Management Application and Diarrhea Suppressant Application for the Years 2015, 2025 & 2030
  • TABLE 401: Africa Recent Past, Current & Future Analysis for Morphine Drugs by End-Use - Hospitals & Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 402: Africa Historic Review for Morphine Drugs by End-Use - Hospitals & Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 403: Africa 15-Year Perspective for Morphine Drugs by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2015, 2025 & 2030
  • TABLE 404: Africa Recent Past, Current & Future Analysis for Morphine Drugs by Distribution Channel - Hospital Pharmacies, Retail Pharmacies, Online Pharmacies and Other Distribution Channels - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 405: Africa Historic Review for Morphine Drugs by Distribution Channel - Hospital Pharmacies, Retail Pharmacies, Online Pharmacies and Other Distribution Channels Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 406: Africa 15-Year Perspective for Morphine Drugs by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Retail Pharmacies, Online Pharmacies and Other Distribution Channels for the Years 2015, 2025 & 2030

IV. COMPETITION